Literature DB >> 11862357

Effects of alpha 4/beta 2- and alpha 7-nicotine acetylcholine receptor agonists on prepulse inhibition of the acoustic startle response in rats and mice.

Rudy Schreiber1, Marion Dalmus, Jean De Vry.   

Abstract

RATIONALE: Nicotine and agonists at subtypes of the nicotine acetylcholine receptor (nAChR) affect auditory gating, but the magnitude and direction of such effects appear highly variable. This variability may be due to differences in the tested dose range, selectivity of the test compound, species and strain, and suggests that nAChR subtypes are differentially involved in the control of auditory gating. OBJECTIVES AND METHODS: This study aimed to characterise the effects of nicotine and agonists with preferential activity at alpha4/beta2- and alpha7-nAChRs on auditory sensorimotor gating using a prepulse inhibition (PPI) paradigm. Similar experimental conditions were employed in rats and two strains of mice. The paradigm used startle stimuli of 120 dB and prepulse intensities of 3, 6 and 12 dB above a background of 70 dB.
RESULTS: In Sprague-Dawley rats, nicotine disrupted PPI [minimal effective dose (MED): 1 mg/kg, SC] and this effect was mimicked by the potent nAChR agonist, epibatidine, (MED: < or = 0.001 mg/kg, IP) and the potent, and relatively selective, alpha4/beta2-nAChR agonist A-85380 (MED: < or = 0.1 mg/kg, IP). The effects of epibatidine, A-85380 and, to a lesser extent, nicotine were blocked by the non-selective nAChR antagonist mecamylamine. The relatively selective alpha7-nAChR agonists, GTS-21 and AR-R-17779, did not affect PPI in a consistent manner, both in rats and in DBA/2 mice, a strain expressing a disrupted gating phenotype, presumably due to altered activity of hippocampal alpha7-nAChRs. In BALB/c mice, a strain expressing a normal gating phenotype, nicotine (MED: 10 mg/kg, SC), epibatidine (MED: 0.03 mg/kg, IP) and A-85380 (MED: 0.3 mg/kg, IP) predominantly augmented PPI and mecamylamine attenuated these effects.
CONCLUSIONS: The present results confirm that the effects of nAChR agonists on PPI are species dependent and suggest that stimulation of heteromeric nAChRs containing both alpha and beta subunits, and possibly of the alpha4/beta2 type, affect sensorimotor gating. Evidence supporting a role for alpha7-nAChRs in the control of PPI of the acoustic startle response was not obtained.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11862357     DOI: 10.1007/s00213-001-0927-8

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  27 in total

1.  Effects of haloperidol, clozapine, and quetiapine on sensorimotor gating in a genetic model of reduced NMDA receptor function.

Authors:  Gary E Duncan; Sheryl S Moy; Jeffery A Lieberman; Beverly H Koller
Journal:  Psychopharmacology (Berl)       Date:  2005-12-16       Impact factor: 4.530

2.  Cysteamine treatment ameliorates alterations in GAD67 expression and spatial memory in heterozygous reeler mice.

Authors:  Ammar Kutiyanawalla; Wanwisa Promsote; Alvin Terry; Anilkumar Pillai
Journal:  Int J Neuropsychopharmacol       Date:  2011-07-22       Impact factor: 5.176

3.  Serotonergic involvement in the amelioration of behavioral abnormalities in dopamine transporter knockout mice by nicotine.

Authors:  Osamu Uchiumi; Yoshiyuki Kasahara; Asami Fukui; F Scott Hall; George R Uhl; Ichiro Sora
Journal:  Neuropharmacology       Date:  2012-07-15       Impact factor: 5.250

4.  Long-term effects of developmental PCP administration on sensorimotor gating in male and female rats.

Authors:  Bruce A Rasmussen; Jahn O'Neil; Kebreten F Manaye; David C Perry; Yousef Tizabi
Journal:  Psychopharmacology (Berl)       Date:  2006-10-18       Impact factor: 4.530

Review 5.  Nicotinic mechanisms in the treatment of psychotic disorders: a focus on the α7 nicotinic receptor.

Authors:  Ann Olincy; Robert Freedman
Journal:  Handb Exp Pharmacol       Date:  2012

Review 6.  Treating schizophrenia symptoms with an alpha7 nicotinic agonist, from mice to men.

Authors:  Ann Olincy; Karen E Stevens
Journal:  Biochem Pharmacol       Date:  2007-07-17       Impact factor: 5.858

7.  Nicotine effect on prepulse inhibition and prepulse facilitation in schizophrenia patients.

Authors:  L Elliot Hong; Ikwunga Wonodi; Jada Lewis; Gunvant K Thaker
Journal:  Neuropsychopharmacology       Date:  2007-10-24       Impact factor: 7.853

8.  Trace eyeblink conditioning is impaired in α7 but not in β2 nicotinic acetylcholine receptor knockout mice.

Authors:  Kevin L Brown; David M Comalli; Mariella De Biasi; Diana S Woodruff-Pak
Journal:  Front Behav Neurosci       Date:  2010-10-08       Impact factor: 3.558

9.  Nicotine blocks apomorphine-induced disruption of prepulse inhibition of the acoustic startle in rats: possible involvement of central nicotinic alpha7 receptors.

Authors:  Katsuya Suemaru; Kayo Yasuda; Kenta Umeda; Hiroaki Araki; Kazuhiko Shibata; Tominari Choshi; Satoshi Hibino; Yutaka Gomita
Journal:  Br J Pharmacol       Date:  2004-06-14       Impact factor: 8.739

10.  AR-R 17779 improves social recognition in rats by activation of nicotinic alpha7 receptors.

Authors:  Marja Van Kampen; Karin Selbach; Renate Schneider; Elleonore Schiegel; Frank Boess; Rudy Schreiber
Journal:  Psychopharmacology (Berl)       Date:  2004-01-15       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.